So far BIT has been effective on several different Health Issues,
Such as:
Hep C $3.3Billion USD Market
Hep B $59.58 Billion USD Market
HIV $35 Billion USD Market
Covid $40 Billion USD Market
Total $137.88 Billion USD Markets
$209.89 Billion AUD
So BIT only needs a very small percentage of those markets to have a Massive Valuation.
An example would be if BIT were to get just 2% of those Markets,
at a conservative 50% profit ratio (which would likely be much higher)
It would make Profits of $2.09 Billion a Year
CSL has a $129.2 Billion MC
It made $2.2 Billion Profit (NPAT)
Therefore if BIT got just 2% of the market that is has been proven effective in,
It should have a similar Valuation of around $129.2 Billion.
Not to mention BIT may also be effective on and has other compounds for use on other
worldwide health issues such as Dengue, Ebola, Middle East Respiratory virus, Influenza and Zika viruses.
As well as being effective on SARS Variants such as Covid,
And other potential future SARS / Covid variants.
It is in capsule / tablet form,
Needing no special Refrigeration,
Has no degradation even after 7 Years,
And they already have manufactured Kilograms of BIT 225.
So it's cheap to make,
Cost effective to Transport and Store,
Easy to administer with no Injection of Nurse to do so required,
And Stores well with great shelf life.
This makes it even more cost effective
For the consumer / customer,
As well for the entire chain,
To deliver it to customers....
